ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
124.495,68
0,15%
S&P 500
5.304,72
0,70%
US Dollar vs BRL
5,1731
0,00%
Bitcoin
69.245,77
-0,21%
Brent Oil
82,915
0,08%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Trevi Therapeutics Inc (TRVI)

  7. Trevi Therapeutics Inc (TRVI) Notícias

TRVI

Trevi Therapeutics (TRVI)

Trevi Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:TRVI
DataHoraFonteTítuloCódigoCompanhia
24/05/202417:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRVITrevi Therapeutics Inc
24/05/202408:30Business WireFNB Harvest annonce les distributions de mai 2024NASDAQ:TRVITrevi Therapeutics Inc
21/05/202419:34Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TRVITrevi Therapeutics Inc
09/05/202408:30PR Newswire (US)Trevi Therapeutics to Participate in Upcoming ConferencesNASDAQ:TRVITrevi Therapeutics Inc
07/05/202417:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRVITrevi Therapeutics Inc
07/05/202417:05PR Newswire (US)Trevi Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:TRVITrevi Therapeutics Inc
01/05/202417:05PR Newswire (US)Trevi Therapeutics to Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 7, 2024NASDAQ:TRVITrevi Therapeutics Inc
23/04/202408:30Business WireFNB Harvest annonce les distributions d’avril 2024NASDAQ:TRVITrevi Therapeutics Inc
09/04/202408:30PR Newswire (US)Trevi Therapeutics Announces Abstract Presentation at the American Thoracic Society 2024 International ConferenceNASDAQ:TRVITrevi Therapeutics Inc
04/04/202408:30PR Newswire (US)Trevi Therapeutics to Participate in Upcoming April EventsNASDAQ:TRVITrevi Therapeutics Inc
02/04/202408:30PR Newswire (US)Trevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership TeamNASDAQ:TRVITrevi Therapeutics Inc
21/03/202408:30Business WireFNB Harvest annonce les distributions de mars 2024NASDAQ:TRVITrevi Therapeutics Inc
20/03/202417:05PR Newswire (US)Trevi Therapeutics Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business UpdatesNASDAQ:TRVITrevi Therapeutics Inc
13/03/202417:05PR Newswire (US)Trevi Therapeutics to Report Q4 and Year End 2023 Financial Results and Provide a Corporate Update on March 20, 2024NASDAQ:TRVITrevi Therapeutics Inc
28/02/202409:30PR Newswire (US)Trevi Therapeutics to Participate in Upcoming March EventsNASDAQ:TRVITrevi Therapeutics Inc
22/02/202409:30Business WireFNB Harvest annonce les distributions de février 2024NASDAQ:TRVITrevi Therapeutics Inc
14/02/202422:47Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TRVITrevi Therapeutics Inc
06/02/202409:30PR Newswire (US)Trevi Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:TRVITrevi Therapeutics Inc
24/01/202409:30Business WireFNB Harvest annonce les distributions de janvier 2024NASDAQ:TRVITrevi Therapeutics Inc
04/01/202409:30PR Newswire (US)Trevi Therapeutics Provides Business UpdatesNASDAQ:TRVITrevi Therapeutics Inc
29/12/202312:26Business WireFNB Harvest annonce les distributions annuelles finales réinvesties pour 2023NASDAQ:TRVITrevi Therapeutics Inc
21/12/202318:33Business WireFNB Harvest Distributions réinvesties annuelles estimatives révisées pour 2023NASDAQ:TRVITrevi Therapeutics Inc
18/12/202309:30Business WireFNB Harvest annonce les distributions de décembre 2023NASDAQ:TRVITrevi Therapeutics Inc
05/12/202309:30PR Newswire (US)Trevi Therapeutics Announces the Initiation of its Phase 2b CORAL Clinical Trial of Haduvio™ for Chronic Cough in Idiopathic Pulmonary Fibrosis (IPF)NASDAQ:TRVITrevi Therapeutics Inc
30/11/202317:14Business WireFNB Harvest Distributions réinvesties annuelles estimées pour 2023NASDAQ:TRVITrevi Therapeutics Inc
17/11/202309:30Business WireFNB Harvest annonce les distributions de novembre 2023NASDAQ:TRVITrevi Therapeutics Inc
09/11/202318:13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TRVITrevi Therapeutics Inc
09/11/202318:05PR Newswire (US)Trevi Therapeutics Announces Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:TRVITrevi Therapeutics Inc
02/11/202308:30PR Newswire (US)Trevi Therapeutics Announces the Initiation of its Phase 2a RIVER Clinical Trial of Haduvio™ for Refractory Chronic CoughNASDAQ:TRVITrevi Therapeutics Inc
01/11/202317:05PR Newswire (US)Trevi Therapeutics to Report Q3 2023 Financial Results and Provide a Corporate Update on November 9, 2023NASDAQ:TRVITrevi Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:TRVI

Seu Histórico Recente

AMEX
CZG
NASDAQ
ZRBA
ASX
SPFKOB
TSX
HEJ
Horizons Enhanced Income...
NASDAQ
NVUS
Novus Therapeutics
EU
HHPF
Hof Hoorneman Phoenix
BOV
EMAE4
EMAE PN
AMEX
BUS
NASDAQ
CTXRW
Citius Pharmaceuticals
LSE
0REN
Edwards Lifesciences
LSE
0RI4
Elve
BOV
ONCO3M
Oncoclinicas Brasil Serv... ON
NASDAQ
BIS
ProShares UltraShort NAS...
ASX
CLA
Celsius Resources
NASDAQ
ARBK
Argo Blockchain
TSX
ZDY
BMO US Dividend ETF
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados